GBA1 and Parkinson disease: In addition, such mutations are the highest genetic risk factor to develop Parkinson’s disease (PD) with at least 3-25% (depending on ethnicity) of PD patients carrying such a GBA1 variants and reduced GCase activity being a common symptom of PD15,16.